Related Experiment Videos
Descriptive Analysis of the Medication Complexity Among Hypertensive Patients in Tertiary Hospital Cardiology
Yuxiang Pei1, Shuhe Bian2, Kun Wan1
1Executive Office, Medical Supplies Center of People's Liberation Army General Hospital, Beijing, China.
Insights
Hypertensive patients in China often have multiple health conditions and take many medications, increasing risks. This study highlights the need for medication safety strategies, especially for elderly patients, to improve care.
Area of Science:
- Pharmacology
- Geriatrics
- Public Health
Background:
- Hypertension management in China involves complex patient profiles.
- Real-world data is crucial for understanding medication use in chronic diseases.
Purpose of the Study:
- To analyze comorbidity, polypharmacy, and medication risks in Chinese hypertensive patients.
- To provide real-world evidence on medication complexity in this population.
Main Methods:
- Cross-sectional study using outpatient prescription data from 56 tertiary hospitals in China (2017).
- Analysis of diagnosis, medication, potentially inappropriate medications (PIMs), and potential drug-drug interactions (pDDIs).
Main Results:
- 83.3% of patients had at least one comorbidity.
- Average medication count was 7.44 ± 5.98, increasing with age.
- 10-15% of elderly patients were exposed to PIMs; 12 significant pDDI pairs were identified.
Conclusions:
- Multimorbidity and polypharmacy are common in Chinese hypertensive patients.
- High prevalence of PIMs and pDDIs necessitates targeted medication safety strategies.
- Recommendations include Medication Therapy Management and deprescribing for elderly patients.
Objective:
To systematically analyze the comorbidity status, polypharmacy patterns, and potential medication risks among hypertensive patients attending cardiology departments in tertiary hospitals in China based on real-world outpatient prescription data, providing real-world evidence to describe the medication complexity in this population.
Methods:
A cross-sectional study design was employed. Prescription data of hypertensive patients from the cardiology outpatient departments of 56 tertiary hospitals in mainland China in 2017 were extracted. Diagnosis data, medication data, potentially inappropriate medication (PIM) and potential drug-drug interactions (pDDI) were analyzed. Continuous variables were compared using t‑tests or Mann-Whitney U tests and reported as mean ± standard deviation or median (interquarile range). Linear regression assessed age‑related trends in medication counts. All tests were two‑sided with α = 0.05.
Results:
83.3% of patients had at least one other comorbid condition. The average number of medications per patient was 7.44 ± 5.98, showing a positive correlation with age. Among elderly patients, 10%-15% were exposed to PIMs, and we identified 12 clinically significant pDDI pairs in the cardiology outpatient prescription scenario.
Conclusions:
Multimorbidity and polypharmacy are prevalent among hypertensive patients attending cardiology departments in tertiary hospitals in China. These findings serve as a historical baseline rather than direct clinical guidance. Based on the high prevalence of PIMs in elderly patients and typical clinically significant pDDI identified in this cohort, targeted medication safety strategies (including tailored Medication Therapy Management for multimorbid hypertensive patients and appropriate deprescribing of high-risk agents in the elderly) are suggested to optimize patient-centered comorbidity management.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension I: Introduction